Better outcomes have always been the mission of the life science industry. However, under new reimbursement models where companies are being compensated based on patient outcomes, marketers must migrate their focus from generating high volumes of new patients based on indications to generating positive clinical results for individual patients. Under this scenario, marketers have to engage and cultivate an ongoing dialogue with the "whole patient", helping the brand discern which combinations of products, services, technologies, communications, incentives and support prove most effective in influencing holistic behavioral change.
Enter Signals Analytics, creators of the only cloud-based analytical intelligence platform that transforms the world's unconnected data into actionable insights to enhance therapeutic outcomes, optimize product portfolio health and propel patient-centered innovation. By utilizing our revolutionary Decision Science as a Service platform, life sciences marketers can pinpoint disease, analyze experience, optimize messaging and continuously engage patient populations in order to affect the context in which therapies are being adopted and maximize the value delivered into the healthcare system.
“Signals enables us to understand the real-time patient treatment journey and allows us to build more effective commercialization strategies that closely align with patient needs.”
– VP of Marketing for TA at a Top 5 Pharmaceuticals Company
Signals Impact to Your Business
Demonstrate Value throughout the Continuum of Care by Aligning with Patient Needs, Desires, and Demands
Move Beyond Disease Awareness and Education by Uncovering and Reshaping Patient and Provider Attitudes & Beliefs
Monitor the Environment, Lifestyle and Behavior of Patient Populations to Assure Effective Outreach and Engagement
Incorporate Patient, Provider, Payor, Regulator, Key Opinion Leader and Public Sentiment in Go to Market Strategies
Discover Omnichannel Patient and Provider Experiences to Renovate Approaches and Value Propositions
One of the World’s Largest Life Sciences Companies
Extends Therapeutic Leadership
A leading global pharmaceutical company required better insight into patient engagement and experiences with its Metabolics portfolio. The precision listening and insight detection capabilities of Signals Playbook revealed that although current communications focused on therapeutic features and benefits, patients actually desired comprehensive disease management content. The company is now deploying Signals Playbook across its global marketing and business development organization to empower them with a platform to monitor unmet patient needs, competitor pipeline strategies and emerging therapeutic solutions.
The Signals Difference
Precision Intelligence That Matters Most to Your Enterprise
Real Time Signals Detection with Validated Source Data
Built By Industry Experts For Industry Experts
Rapid Business Impact and Value Right Out of the Box
Machine Learning Combined with Human Intelligence
The Latest From Signals
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
(917) 470 9110
7 Giborei Israel St.
P.O.B 8374, Netanya 4250407, Israel
+972 73 718 1650